Navigation Links
John Theurer Cancer Center presents significant blood cancer research at 2012 ASCO Annual Meeting
Date:5/29/2012

2 1:00pm-5:00pm highlight this one more
  • 8011- Stringent complete response in patients with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib, lenalidomide, and dexamethasone, David H. Vesole, MD, PhD et all. Oral Session: June 3, 2012 8:00am-11:00pm
  • 8016 - Pomalidomide with or without low-dose dexamethasone in patients with relapsed/refractory multiple myeloma: Outcomes in patients refractory to lenalidomide and/or bortezomib, David S. Siegel, MD, PhD et all. Oral Session: June 3, 2012 8:00am-11:00pm
  • 8035 - Response rates to single-agent carfilzomib in patients refractory or intolerant to both bortezomib and immunomodulators in trial PX-171-003-A1, David S. Siegel, MD, PhD et all. Poster Session: June 2, 2012 8:00am-12:00pm
  • TPS6636 - A single-arm, open-label, multicenter study of complete molecular response in patients with newly diagnosed Philadelphia chromosomepositive chronic myeloid leukemia in chronic phase treated with nilotinib, Stuart Goldberg, MD et all. Poster Session: June 4, 2012 1:15pm-5:15pm

    "Our research presented at this conference would not have been possible without the patients who participate in our clinical trials," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., chief innovation officer, professor and vice president of cancer services, John Theurer Cancer Center. "We are thankful to our patients, our researchers, and our partnering institutions who help us bring novel therapies and improved regimens for cancer patients."


    '/>"/>


  • Contact: Amy Leahing
    aleahing@p4strategy.com
    John Theurer Cancer Center
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. John Theurer Cancer Center BMT researchers highlight the importance of social support
    2. John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
    3. National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
    4. Breast cancer treatment resistance linked to signaling pathway
    5. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells
    6. The dietary supplement genistein can undermine breast cancer treatment
    7. Saliva proteins could help detection of oral cancer
    8. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
    9. Breakthrough optical technology to assess colon cancer risk, accuracy
    10. Breast cancer cells recycle to escape death by hormonal therapy
    11. Nanodiamond drug device could transform cancer treatment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
    (Date:3/12/2015)... FAIRFAX, Va. , March 12, 2015 ... company and a member of the Texas Instruments Design ... Chandrababu Naidu has demonstrated its IriShield USB MK2120U ... iris scanning facility for pension distribution. ... and assembled to be marketed in India ...
    (Date:3/12/2015)... 2015 Beta Systems today ... access management (IAM) solution for a fixed price ... System,s new IAM package, customers benefit from the ... multiple IAM implementations across different industries. The new ... as any necessary services and consulting. It spans ...
    Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2
    ... WASHINGTON, D.C.-- In a major step that could revolutionize biomedical ... as well as tumor cells taken from an individual cancer ... been possible. Normal cells usually die in the lab after ... not grow, unaltered, outside of the body. This new ...
    ... throughout the Northern Hemisphere for more than a century and ... lakes located thousands of miles from the nearest city, industrial ... Science Dec. 16, are based on historical changes ... using an approach similar to aquatic archeology. More than three ...
    ... risk of attack has led to the development of ... larval stage. One caterpillar may look like a stick, ... may have its advantages, University of Florida researchers uncovered ... another strategy previously best-known in adult butterflies: mimicry. ...
    Cached Biology News:Georgetown researchers lead discovery expected to significantly change biomedical research 2Nitrogen from humans pollutes remote lakes for more than a century 2Nitrogen from humans pollutes remote lakes for more than a century 3Caterpillars mimic one another for survival 2Caterpillars mimic one another for survival 3
    (Date:3/25/2015)... March 25, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... a result of recent discussions with certain shareholders representing ... the Company, after dealing with certain matters including the ... of shareholders on March 26, 2015 (the "Meeting") it ... of directors will take place when the Meeting reconvenes. ...
    (Date:3/25/2015)... Laboratory workers can turn to ... Balances to get best-performing features while still remaining ... from the trusted brand include: , Cole-Parmer ... efficiency by providing a large weighing surface for ... include parts counting, percent weighing, checkweighing, animal/dynamic weighing, ...
    (Date:3/25/2015)... CORAL SPRINGS, Fla. , March 25, 2015 ... (HIT) strategy and management consulting firm, has launched ... reference publication to simplify tracking of ePrescribing regulatory ... "The ePrescribing regulatory landscape continues to ... offerings to deliver what the industry, and ultimately ...
    (Date:3/25/2015)... LOUIS and the HAGUE, Netherlands ... of two-year results of LES Stimulation therapy for chronic ... the journal Surgery [ Surgery . ... efficacy of its minimally-invasive therapy. The ... average duration of 11 years and taking prescribed daily ...
    Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5New Economical Top-Loading and Analytical Symmetry Balances from Cole-Parmer 2Point-of-Care Partners Launches the ePrescribing State Law Capsule 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3
    ... 9, 2011 Rhythm announced today results demonstrating that ... in restoring normal gastric function in animal models of ... The results were the subject of an oral presentation ... Harvard Medical School) titled "RM-131: A Potent Gastroprokinetic Agent" ...
    ... BD Diagnostics, a segment of global medical technology ... BDX ), and Diagenode SA, an international biotech company ... seven initial molecular diagnostic assays on the BD MAX™ ... nervous system diseases.   "Our agreement with ...
    ... 9, 2011 caprotec bioanalytics GmbH, a ... Mass Spectrometry (CCMS) platform technology for the analysis of ... closing of EUR 1 million ($1.4 M) to its ... to EUR 5 million ($7.2 M). The capital increase ...
    Cached Biology Technology:Rhythm's RM-131 Restores GI Function as a Potent Ghrelin Prokinetic 2BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 2BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 3BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System 4caprotec bioanalytics Increases Series B Financing in Second Closing to EUR 5 Million 2
    ...
    ... assay (ELISA) test kits are qualitative one-step ... detection of drugs and/or their metabolites in ... forensic use only. It is recommended that ... quantitative method such as GC/MS. The ...
    96 Well Base Plate...
    ... Inhibitor is a recombinant human protein produced in ... neutral pancreatic RNase A type enzymes. The ... binds RNases in a 1:1 ratio. The enzyme ... many tissues and cell types. Addition of the ...
    Biology Products: